<DOC>
	<DOCNO>NCT02691000</DOCNO>
	<brief_summary>The Light-Heart study randomize , double-blind , control trial investigate effect bright white light ( BWL ) therapy depressive symptom , quality life , function patient Stage B heart failure . The study randomize , double-blind , control trial 8 week morning BWL therapy compare morning dim red light ( DRL ) treatment old ( 60 year old ) 122 Stage B ( early , asymptomatic ) HF patient .</brief_summary>
	<brief_title>The Light Heart Study : Daily Light Box Use Depressive Symptoms Patients With Stage B Heart Failure</brief_title>
	<detailed_description>The Light-Heart study randomize , double-blind , control trial 8 week morning BWL therapy , compare DRL old , Stage B HF patient clinically significant level depressive symptom . The primary hypothesis propose study compare DRL , BWL therapy associate significantly great reduction depressive symptom . Important information compliance tolerability associate BWL intervention Stage B HF patient also gather . The investigator examine whether BWL therapy associate great improvement quality life subjective functioning compare DRL . Finally , researcher investigate whether BWL associate sustained improvement depressive symptom 2 4 week follow end intervention compare DRL . One hundred twenty-two older adult ( ≥60 year ) Stage B HF depressive symptom ( Beck Depression Inventory/BDI score ≥10 ) recruit several University California , San Diego ( UCSD ) Veteran 's Affairs ( VA ) cardiology clinic . The baseline assessment include evaluation depressive symptom ( BDI ) , quality life ( Quality Life Enjoyment Satisfaction questionnaire ) , subjective functioning ( Short Form-36 ) , assessment patient expectation regard study intervention ( single question , 5 point scale ) . These measure assess 4 8 week treatment 2 4 week follow end BWL therapy intervention along side effect ( Frequency , Intensity , Burden Side Effects Rating ) . Participants randomize receive BWL ( n=61 ) DRL ( n=61 ) light therapy box ( Litebook® Elite ; Litebook® Inc. , Medicine Hat , CA ) use home 60 minute morning 8 week . If participant currently receive treatment ( e.g . antidepressant therapy ) , participant continue usual treatment study . Participants tell effect particular light therapy protocol mood function investigate . Participants make aware treatment condition interest comparison condition participant randomly assign one group . Participants tell different color light used BWL treatment interest . The Litebooks® look identical except color light . Weekly telephone call encourage compliance , compliance meter record Litebooks® turn . A blood sample also collect patient ass biomarkers .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>age ≥ 60 year Written inform consent BDI score ≥ 10 Stage B heart failure diagnosis antidepressant pharmacotherapy stable dose antidepressant ( &gt; 8 week ) stable dose cardiac medication ( &gt; 8 week ) selfreported history bipolar disorder psychiatric diagnosis Structured Clinical Interview Diagnostic Statistical Manual ( DSM ) ( ie ; bipolar disorder , schizophrenia , schizoaffective disorder , major neurocognitive disorder ) serious suicide homicide risk ( outpatient care judge unsafe ) recent initiation change dose antidepressant cardiac medication ( within past 8 week ) current use supplement putative effect mood sleep ( e.g St. John 's Wort , melatonin ) recent initiation evidence base psychotherapy mood prior use BWL therapy unstable medical illness require hospitalization uncontrolled seizure disorder retinopathy macular degeneration shift work</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>depression</keyword>
	<keyword>depressive symptom</keyword>
	<keyword>stage b heart failure</keyword>
	<keyword>bright white light</keyword>
	<keyword>light therapy</keyword>
</DOC>